KoBioLabs Surges on Celltrion Deal...ECM Boosters Gain Traction [K-bio pulse] 김진수 2026.03.26 오전 08:00 Celltrion biosimilars expand dominance in Japan’s oncology market 임정요 2025.06.13 오전 10:11 Celltrion Unfazed by U.S. Price Cuts, Tariffs Zymfentra Drag Tied to Insurance 송영두 2025.05.15 오후 03:23 Celltrion Posts Record Q2 Results, Accelerates Global Pharma Ambitions 나은경 2025.07.24 오전 10:58 Celltrion’s Zymfentra Prescriptions Surge in U.S., Hitting Record Monthly High 송영두 2026.03.18 오전 08:46 Celltrion’s Remsima Tops KRW 1 Trillion in Annual Sales for Second Straight Year 김새미 2026.02.10 오전 10:05 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years 송영두 2025.05.28 오전 10:01 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 Celltrion, Inc. Completes EU Launch of 'Aptozma' 김새미 2026.01.30 오전 10:44 더 보기 로딩중..
Remsima
Remsima
![KoBioLabs Surges on Celltrion Deal...ECM Boosters Gain Traction [K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/03/PS26032600327b.jpg)
